Prevalence of Adverse Drug Reactions: Comparing Crotalidae Immune Polyvalent Antivenoms F(ab') and F(ab) in a Galactose-alpha-1,3-galactose (alpha-gal) Endemic Area.
Supporting Files
-
March 2026
-
Available in CDC Stacks on June 16, 2026, 12:00 AM
File Language:
English
Details
-
Alternative Title:Annals of Emergency Medicine, 2026, v. 87, no. 3: Prevalence of Adverse Drug Reactions: Comparing Crotalidae Immune Polyvalent Antivenoms F(ab') and F(ab) in a Galactose-alpha-1,3-galactose (alpha-gal) Endemic Area.
-
Journal Article:Annals of Emergency Medicine
-
Personal Author:
-
Description:North American pit viper antivenoms, CroFab® and ANAVIP®, contain galactose-α-1,3-galactose (α-GAL) oligosaccharide. We compared adverse drug reactions, including presumed anaphylaxis, following administration of these antivenoms and investigated biological plausibility of these antivenoms leading to anaphylaxis in α-GAL-immunoglobulin (Ig) E-sensitized individuals.
We performed 2 studies. A retrospective chart review from the Arkansas Poison Center (May 2021 to July 2023) identified adverse drug reactions and presumed anaphylaxis in patients treated with crotaline antivenom. Two allergists (JK, LM), blinded to the antivenom used, adjudicated presumed anaphylaxis cases. To assess whether antivenoms could activate basophils from α-GAL-IgE-sensitized individuals, basophil activation tests were performed on blood from 5 α-GAL-IgE-sensitized participants with a history of mammalian meat allergy. Basophil activation was assessed by %CD63 upregulation.
Adverse drug reactions without presumed anaphylaxis occurred in 7 out of 171 (4.1%) Fab recipients versus 8 out of 37 (21.6%) F(ab')
recipients (Δ=17.5%, 95% confidence interval CI 4.0 to 31.0). Presumed anaphylaxis was observed in 3 out of 171 (1.8%) for Fab and 6/37 (16.2%) for F(ab')
(Δ=14.3%, 95% CI 2.5 to 26.2). In the basophil activation tests, the mean EC
for basophil CD63 activation was 144-fold higher for Fab (mean, standard deviation; 647 μg/mL of antivenom 627) compared to F(ab')
(4.48 μg/mL of antivenom 2.75).
We demonstrate a substantial incidence of adverse drug reactions and presumed anaphylaxis to crotaline antivenoms in an α-GAL endemic region, with F(ab')
antivenom associated with more reactions than F(ab). Clinicians in α-GAL endemic regions should be cautious in the use of antivenoms, especially for patients with α-GAL allergy. -
Content Notes:Author manuscript
-
Subjects:
-
Source:Annals of Emergency Medicine, 2026, v. 87, no. 3
-
DOI:
-
ISSN:0196-0644 ; 1097-6760
-
Pubmed ID:40817895
-
Pubmed Central ID:PMC13270925
-
Document Type:
-
Funding:
-
Genre:
-
Pages in Document:292-302 (18 pdf pages)
-
Volume:87
-
Issue:3
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha-512:2b6d9d5fc367900d7c0b18c4782c6913584a842c045713e2655a0f7d6f48a1cc2807ec1501643a673d72c698b2af4dafe6be05f1853077cc455c2af7d0436358
Supporting Files
File Language:
English
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access